Literature DB >> 33728001

Role of urine studies in asymptomatic febrile neutropenic patients presenting to the emergency department.

Hady Zgheib1, Aline El Zakhem2, Cynthia Wakil1, Mohamad Ali Cheaito1, Rola Cheaito1, Antoine Finianos2, Ralphe Bou Chebl1, Rima Kaddoura1, Nader Al Souky1, Imad El Majzoub1.   

Abstract

BACKGROUND: The role of urine studies in the detection of urinary tract infection (UTI) in febrile neutropenic patients with urinary symptoms (having a urinary catheter or having a positive urine analysis) is inarguable. However, the evidence is scarce regarding the indication for urine studies in asymptomatic (i.e., without urinary symptoms) patients with febrile neutropenia (FN) presenting to the emergency department (ED). The aim of this study is to evaluate the need for obtaining urine studies in asymptomatic febrile neutropenic patients.
METHODS: This was a retrospective cohort study conducted on adult cancer patients who presented to the ED with FN and had no urinary symptoms. We included all ED presentations of eligible patients between January 2013 and September 2018. Student's t-test and Wilcoxon rank-sum test were used for continuous data, while Chi-square and Fisher's exact tests were used for categorical data. Participants were divided into two groups based on their urine culture (UC) results: negative and positive UCs. Two cut-offs were used for positive UC results: ≥105 cfu/mL and ≥104 cfu/mL.
RESULTS: We included 284 patients in our study. The age of our patient population was 48.5±18.5 years. More than two-thirds (68.7%) of patients had severe neutropenia, while only 3.9% and 9.9% of the patients had positive UCs at ≥105 cfu/mL and ≥104 cfu/mL, respectively. UCs were expectedly positive in most patients with urinalysis (UA) abnormalities. However, 27.3% and 32.1% of patients with positive UCs at ≥105 cfu/mL and ≥104 cfu/mL respectively had a normal UA.
CONCLUSIONS: In our study, the incidence of UTI in adult febrile neutropenic cancer patients who present to the ED without urinary symptoms is low. Consequently, routine urine testing may not be warranted in this population, as it adds unnecessary financial burdens on the patients and delays timely management. Copyright: © World Journal of Emergency Medicine.

Entities:  

Keywords:  Adult; Cancer; Emergency department; Febrile neutropenia; Urine testing

Year:  2021        PMID: 33728001      PMCID: PMC7947557          DOI: 10.5847/wjem.j.1920-8642.2021.02.003

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  28 in total

1.  Management of febrile neutropenia: ESMO Clinical Practice Guidelines.

Authors:  J de Naurois; I Novitzky-Basso; M J Gill; F Marti Marti; M H Cullen; F Roila
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

Authors:  J Klastersky; J de Naurois; K Rolston; B Rapoport; G Maschmeyer; M Aapro; J Herrstedt
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

3.  The Diagnosis of UTI: Colony Count Criteria Revisited.

Authors:  Kenneth B Roberts; Ellen R Wald
Journal:  Pediatrics       Date:  2018-01-16       Impact factor: 7.124

Review 4.  Management of fever in patients with cancer and treatment-induced neutropenia.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

5.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

Review 6.  Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.

Authors:  F de Lalla
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

7.  Pyuria is absent during urinary tract infections in neutropenic patients.

Authors:  I L M Klaassen; V de Haas; J A E van Wijk; G J L Kaspers; M Bijlsma; A Bökenkamp
Journal:  Pediatr Blood Cancer       Date:  2010-10-14       Impact factor: 3.167

8.  Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.

Authors:  María E Santolaya; Ana M Alvarez; Carmen L Avilés; Ana Becker; Claudio Mosso; Miguel O'Ryan; Ernesto Payá; Carmen Salgado; Pamela Silva; Santiago Topelberg; Juan Tordecilla; Mónica Varas; Milena Villarroel; Tamara Viviani; Marcela Zubieta
Journal:  Pediatr Infect Dis J       Date:  2007-09       Impact factor: 2.129

9.  Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.

Authors:  Sam E Grigg; Patrick Date; Zoe Loh; Ortis Estacio; Douglas F Johnson; Eliza A Hawkes; Andrew Grigg
Journal:  Support Care Cancer       Date:  2018-09-27       Impact factor: 3.603

10.  Patterns of microbial growth in urine cultures in a pediatric hematology/oncology unit over a one-year period: a single institution study.

Authors:  Nader Hirmas; Sawsan Mubarak; Iyad Sultan
Journal:  Int J Pediatr Adolesc Med       Date:  2017-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.